Daré Bioscience (DARE) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 11, 2026, with voting available online or virtually at the meeting.

• Shareholders are encouraged to review proxy materials and vote on key proposals affecting governance and compensation.

Voting matters and shareholder proposals

• Election of two Class III director nominees: Sabrina M. Johnson and Gregory W. Matz.

• Ratification of Haskell & White, LLP as independent auditor for fiscal 2026.

• Advisory vote on executive compensation and on the frequency of future say-on-pay votes (recommended: annually).

• Approval sought for potential future issuance of shares to Lincoln Park Capital Fund, LLC.

• Proposal to amend the 2022 Stock Incentive Plan to add 1,500,000 shares.

• Proposals to adjourn the meeting if more time is needed to solicit votes for Proposals 5 or 6.

Board of directors and corporate governance

• Board recommends voting in favor of all director nominees and all proposals.